To investigate the functional capacity of T cells in BC patients and evaluate their correlation with immune subsets identified by mass cytometry, we stimulated PBMCs from BC patients with human T cell activator CD3/CD28 DynaBeads, and measured IFNγ production by flow cytometry. This evidence concerns the gene CD28 and breast cancer.